Canada markets closed
  • S&P/TSX

    19,107.77
    -166.23 (-0.86%)
     
  • S&P 500

    4,063.04
    -89.06 (-2.14%)
     
  • DOW

    33,587.66
    -681.50 (-1.99%)
     
  • CAD/USD

    0.8248
    +0.0004 (+0.04%)
     
  • CRUDE OIL

    65.67
    -0.41 (-0.62%)
     
  • BTC-CAD

    62,748.85
    -5,906.68 (-8.60%)
     
  • CMC Crypto 200

    1,475.23
    -88.60 (-5.67%)
     
  • GOLD FUTURES

    1,817.00
    -5.80 (-0.32%)
     
  • RUSSELL 2000

    2,135.14
    -71.85 (-3.26%)
     
  • 10-Yr Bond

    1.6950
    +0.0710 (+4.37%)
     
  • NASDAQ futures

    13,013.50
    +15.00 (+0.12%)
     
  • VOLATILITY

    27.59
    +5.75 (+26.33%)
     
  • FTSE

    7,004.63
    +56.64 (+0.82%)
     
  • NIKKEI 225

    28,147.51
    -461.08 (-1.61%)
     
  • CAD/EUR

    0.6829
    +0.0005 (+0.07%)
     

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytoDyn Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2021 - CYDY

  • Oops!
    Something went wrong.
    Please try again later.
Newsfile Corp.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

New York, New York--(Newsfile Corp. - April 13, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of CytoDyn Inc. ("CytoDyn") (OTC: CYDY) between March 27, 2020 and March 9, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of Washington. To get more information go to:

https://www.zlk.com/pslra-1/cytodyn-inc-loss-submission-form?prid=14675&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.

If you suffered a loss in CytoDyn you have until May 17, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80371